<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><description>医药行业一致性评价工作在如火如荼的进行中，作为行业的一份子，愿本愚公之念，出蝼蚁 之力，献寸光之策。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 09 Apr 2021 23:22:15 +0800</pubDate><image><url>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</url><title>药春秋 | wechat-feeds</title><link>http://MzI0MDM2NTA4NQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>（4.2~4.8）一致性评价周动态，2款注射剂首家过评…</title><link>https://mp.weixin.qq.com/s/xou_nnCyRzvxhtY9qpSwWQ</link><description></description><content:encoded><![CDATA[（4.2~4.8）一致性评价周动态，2款注射剂首家过评…]]></content:encoded><pubDate>Fri, 09 Apr 2021 21:42:20 +0800</pubDate></item><item><title>亮丙瑞林三分天下，决胜在“更加长效”，后来者望尘莫及！</title><link>https://mp.weixin.qq.com/s/JAHHJ8xD1mm76JNTRKP0vw</link><description></description><content:encoded><![CDATA[亮丙瑞林三分天下，决胜在“更加长效”，后来者望尘莫及！]]></content:encoded><pubDate>Fri, 09 Apr 2021 21:42:20 +0800</pubDate></item><item><title>刚刚！NMPA发布第四十批参比目录</title><link>https://mp.weixin.qq.com/s/pAxhzAeye1t-Yctc0dCXLg</link><description></description><content:encoded><![CDATA[刚刚！NMPA发布第四十批参比目录]]></content:encoded><pubDate>Fri, 09 Apr 2021 21:42:20 +0800</pubDate></item><item><title>五省市集采落地，中选药稳拿七成采购总量</title><link>https://mp.weixin.qq.com/s/qI0nNyy-yPjJH-25mt6n4g</link><description></description><content:encoded><![CDATA[五省市集采落地，中选药稳拿七成采购总量]]></content:encoded><pubDate>Fri, 09 Apr 2021 21:42:20 +0800</pubDate></item><item><title>129个常用药联动降价！</title><link>https://mp.weixin.qq.com/s/Ez-K81ooVf7-fyktRazbcw</link><description></description><content:encoded><![CDATA[129个常用药联动降价！]]></content:encoded><pubDate>Fri, 09 Apr 2021 21:42:20 +0800</pubDate></item><item><title>未过评品种集采来袭 - 科伦揽下4席，成最大赢家！</title><link>https://mp.weixin.qq.com/s/uuTF_S0SQnR49xVIvuiYWQ</link><description></description><content:encoded><![CDATA[未过评品种集采来袭 - 科伦揽下4席，成最大赢家！]]></content:encoded><pubDate>Thu, 08 Apr 2021 21:36:18 +0800</pubDate></item><item><title>人福药业丨2款手术围期注射液传来喜讯</title><link>https://mp.weixin.qq.com/s/fu4ZILbkWSqBzATEmN9JWg</link><description></description><content:encoded><![CDATA[人福药业丨2款手术围期注射液传来喜讯]]></content:encoded><pubDate>Thu, 08 Apr 2021 21:36:18 +0800</pubDate></item><item><title>两千多个医保药，医院不许卖了！</title><link>https://mp.weixin.qq.com/s/DzYNZhZrStdIpDAbjS7RLA</link><description></description><content:encoded><![CDATA[两千多个医保药，医院不许卖了！]]></content:encoded><pubDate>Thu, 08 Apr 2021 21:36:18 +0800</pubDate></item><item><title>药价大降，最高达81.7%！</title><link>https://mp.weixin.qq.com/s/gZ3jo4wP6FSDvTnmfEjpvg</link><description></description><content:encoded><![CDATA[药价大降，最高达81.7%！]]></content:encoded><pubDate>Wed, 07 Apr 2021 21:38:16 +0800</pubDate></item><item><title>潜力抗癫痫药市场，Top 5揽下八成份额，给力！</title><link>https://mp.weixin.qq.com/s/kgM3j2ODhj-JVqaL-XaskA</link><description></description><content:encoded><![CDATA[潜力抗癫痫药市场，Top 5揽下八成份额，给力！]]></content:encoded><pubDate>Wed, 07 Apr 2021 21:38:16 +0800</pubDate></item><item><title>近千个药品被取消挂网</title><link>https://mp.weixin.qq.com/s/uo1u8HcqzpYQ3NxsOh5Cuw</link><description></description><content:encoded><![CDATA[近千个药品被取消挂网]]></content:encoded><pubDate>Wed, 07 Apr 2021 21:38:16 +0800</pubDate></item><item><title>57个大品种启动GPO议价，涉及多西他赛、亮丙瑞林...</title><link>https://mp.weixin.qq.com/s/SIdWq6rlJdB4BguzN79Edw</link><description></description><content:encoded><![CDATA[57个大品种启动GPO议价，涉及多西他赛、亮丙瑞林...]]></content:encoded><pubDate>Wed, 07 Apr 2021 21:38:16 +0800</pubDate></item><item><title>吸入剂优质赛道，国产品牌迅速崛起，已是入场好时机？</title><link>https://mp.weixin.qq.com/s/FchgnCTVu-63spkYejfEYA</link><description></description><content:encoded><![CDATA[吸入剂优质赛道，国产品牌迅速崛起，已是入场好时机？]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:37:43 +0800</pubDate></item><item><title>二甲双胍，传来新消息！</title><link>https://mp.weixin.qq.com/s/QpP5Dbus3kWiO8qToVbXKw</link><description></description><content:encoded><![CDATA[二甲双胍，传来新消息！]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:37:43 +0800</pubDate></item><item><title>11品种纳入带量采购；量大、获批早等药品优势明显</title><link>https://mp.weixin.qq.com/s/ePvWU8mwRQV1udsLTz-njw</link><description></description><content:encoded><![CDATA[11品种纳入带量采购；量大、获批早等药品优势明显]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:37:43 +0800</pubDate></item><item><title>涉及原料药垄断，知名药企再遭巨额罚款...</title><link>https://mp.weixin.qq.com/s/A9YwZo_yzK2QQbPBFEo8wg</link><description></description><content:encoded><![CDATA[涉及原料药垄断，知名药企再遭巨额罚款...]]></content:encoded><pubDate>Tue, 06 Apr 2021 21:37:43 +0800</pubDate></item><item><title>药品注册：从入门到放弃……</title><link>https://mp.weixin.qq.com/s/gnGh7tWaQV6OlG7lzPlHew</link><description></description><content:encoded><![CDATA[药品注册：从入门到放弃……]]></content:encoded><pubDate>Sat, 03 Apr 2021 21:36:32 +0800</pubDate></item><item><title>丽珠财报：17亿独家注射剂“疯涨”，助力集团净利提高31%</title><link>https://mp.weixin.qq.com/s/-ahdsEUdZIfhzRWmkcGc1g</link><description></description><content:encoded><![CDATA[丽珠财报：17亿独家注射剂“疯涨”，助力集团净利提高31%]]></content:encoded><pubDate>Fri, 02 Apr 2021 21:39:24 +0800</pubDate></item><item><title>吸入剂BE研究：国内外异同要点一览</title><link>https://mp.weixin.qq.com/s/fNUe4ktdqEr6KJVDEi_tBA</link><description></description><content:encoded><![CDATA[吸入剂BE研究：国内外异同要点一览]]></content:encoded><pubDate>Fri, 02 Apr 2021 21:39:24 +0800</pubDate></item><item><title>161个品种新增挂网</title><link>https://mp.weixin.qq.com/s/L1vCLbIkObFhL2Jvc8nzcQ</link><description></description><content:encoded><![CDATA[161个品种新增挂网]]></content:encoded><pubDate>Fri, 02 Apr 2021 21:39:24 +0800</pubDate></item></channel></rss>